Running Clinical Trials in Asia-Pacific: A Regulatory and Cost Comparison Across Nine Markets
Asia-Pacific (APAC) has moved from being a low-cost recruitment option to a genuine strategic destination for clinical development. The region now combines large, diverse and often



